Applied Therapeutics Inc
NASDAQ:APLT

Watchlist Manager
Applied Therapeutics Inc Logo
Applied Therapeutics Inc
NASDAQ:APLT
Watchlist
Price: 9.9 USD -3.32% Market Closed
Market Cap: 1.1B USD
Have any thoughts about
Applied Therapeutics Inc?
Write Note

EV/FCFF
Enterprise Value to FCFF

-13.9
Current
-1.2
Median
3.8
Industry
Lower than median
Lower than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
-13.9
=
Enterprise Value
1B USD
/
FCFF
-73.2m USD
All Countries
Close
Market Cap EV/FCFF
US
Applied Therapeutics Inc
NASDAQ:APLT
1.1B USD -13.9
FR
Pharnext SCA
OTC:PNEXF
6T USD -234 315.4
US
Abbvie Inc
NYSE:ABBV
302.3B USD 22.6
US
Amgen Inc
NASDAQ:AMGN
160.6B USD 33.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.3B USD -84.1
US
Gilead Sciences Inc
NASDAQ:GILD
118.3B USD 11.3
US
Epizyme Inc
F:EPE
94.1B EUR -478.7
AU
CSL Ltd
ASX:CSL
138.5B AUD 66.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
90.4B USD 25.1
US
Seagen Inc
F:SGT
39.3B EUR -57.8
NL
argenx SE
XBRU:ARGX
33.4B EUR -99.5
 
US
Applied Therapeutics Inc
NASDAQ:APLT
Average EV/FCFF: 31.7
Negative Multiple: -13.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -234 315.4
US
Abbvie Inc
NYSE:ABBV
22.6
US
Amgen Inc
NASDAQ:AMGN
33.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -84.1
US
Gilead Sciences Inc
NASDAQ:GILD
11.3
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.7
AU
CSL Ltd
ASX:CSL
66.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
25.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -57.8
NL
argenx SE
XBRU:ARGX
Negative Multiple: -99.5

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A

See Also

Discover More